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 Reducing risk following self-harm - the need for careful prescribing 
 
Self-harm as a risk factor for suicide 
Self-harm is the strongest risk factor for suicide.1,2 Globally, suicide is the second 
most common cause of death among 10-24 year olds after road traffic incidents.3 
Non-fatal self-harm is the strongest risk factor for subsequent suicide,2 and Recent 
evidence indicates that the incidence of self-harm may be increasing among 
adolescents.4 Older people who self-harm have an increased suicidal intent,
5 and, 
although repetition rates are low compared with middle-aged adults, self-harm is 
more often fatal in older adults.6 
Tyrell and colleagues7 identify antidepressants and analgesics as common drugs 
used in self-poisoning in young people. Overdose as a form of self-harm may be with 
prescription-only or sales-restricted drugs, often in combination with alcohol.8 Older 
people who self-harm have an increased suicidal intent,
6 and, although repetition 
rates are low compared with middle-aged adults, self-harm is more often fatal in 
older adults.7 Depression is also a key risk factor for suicide.9 Older adults with 
previously diagnosed co-morbid mental and physical health conditions have an 
increased risk of self-harm.6,10  
 
 
The Inverse Care Law 
Recent evidence also suggests that the Inverse Care Law,11 whereby quantity or 
quality of healthcare service provision is inversely associated with the level of 
healthcare need, operates in the clinical management of self-harm in all age groups. 
Thus, self-harm incidence is elevated across the life-course in practice populations in 
deprived areas.4,10,12 In children and adolescents,4 and among adults of working 
age,13  the likelihood of referral to specialist services following self-harm was found to 
be lowest in practices in the most deprived localities, where incidence of self-harm 
was highest. Poisonings show a close relationship with deprivation, with the 
incidence of poisoning from all substances rising with increasing level of 
socioeconomic deprivation.7 
 
 Patient safety 
The NICE guidance for the long-term management of self-harm (CG133)
14 states 
that: “When prescribing drugs for associated mental health conditions to people who 
self-harm, take into account the toxicity of the prescribed drugs in overdose...In 
particular, do not use tricyclic antidepressants, such as dosulepin, because they are 
more toxic”. The clinical importance of this statement is indicated by the fact that it 
was only one of three (among a total of 57 recommendations in CG133) to be 
emphasised as a ‘Do Not Do’ recommendation.15 
 
Despite this unequivocal recommendation, three recent studies conducted by the 
same research groupteam, in UK primary care patient cohorts, demonstrated a high 
frequency of tricyclic antidepressant (TCA) prescribing, medication that is known to 
be potentially fatally toxic in overdose.16 Thus, 6.2% of adolescent (aged 10-19 
years),4 9.6% of adults aged 15-64 years,13 and 11.8% of older adults10 were 
prescribed a TCA within 12 months of their index self-harm episode. The proportion 
of cohort members aged 15-64 years prescribed a TCA did not fall discernibly across 
the 12 year observation period; thus, although CG133 was published in November 
2011, during 2012-2013 almost 9 percent still received this highly toxic 
antidepressant. In that study, most patients (70.4%) had a diagnosis of depression 
prior to the date of their first TCA prescription during follow-up, and 10.4% had a 
diagnosis of depression recorded on the same day as this prescription was issued.13 
It is not known from these studies whether the TCAs were prescribed for depression 
or pain; although the latter would be unlikely in young people, this would be a 
possibility in older adults. Whatever the diagnostic label, however, the prescription of 
TCAs potentially compromises patient safety. In addition, opioid prescribing in the 
year following self-harm was reported: 10% in adults of working age.13 Conversely, 
nearly 11% of persons aged 15-64 years who had self-harmed had a psychiatric 
diagnosis documented, but were not subsequently prescribed medication or referred 
to specialist services.13 The observed trends for higher likelihood of psychotropic 
medication prescribing and lower likelihood of referral to specialist services with 





Elevated self-harm risk in the first 28 days of starting and stopping antidepressants 
emphasises the need for careful monitoring of patients during these periods.17 After 
self-harm in any patient, but particularly in an older adult,10 consideration of referral 
for psychological therapy or psychiatric opinion, and consideration of alternative 
medication, with particular avoidance of TCAs, might reduce the risk of escalating 
self-harm behaviour and associated mortality risk. Clinicians working with more 
deprived practice populations might particularly be reminded to consider alternative 
management options to prescribing. 
 
The Safer Prescribing toolkit produced by the National Confidential Inquiry into 
Suicide and Safety in Mental Health18 highlights three points relevant to patient 
safety following self-harm: 1. encourage the safer prescribing of opioids; 2. ensure 
that there is a service in place for people with complex depression; 3. be alert to 
people with markers of risk such as frequent consultation, multiple psychotropic 
medication and specific drug combinations. The toolkit suggests that general 
practitioners should be aware of the dangers associated with the prescribing of 
TCAs.18 
 
Managing people following self-harm 
Self-harm is a complex and often ingrained behaviour.14 People who have harmed 
themselves may be fearful of disclosing their behaviour due to stigma and shame.19 
The clinician should show empathy for and understanding of the patient who has 
self-harmed, offering support, and exploring the needs and expectations of the 
individual. This should include an exploration of mood, social factors and risk of self-
harm repetition, as well as considering the physical consequences of self-harm and 
injury. 18,20 Consideration of whether referral for further care is also needed, 
particularly in more deprived areas, and has the potential to reduce the inequality of 
access to care for people who have harmed themselves. 10,13 In addition, recognition 
of the role of third sector services in supporting people who self-harm is crucial and 
may plug the gap in service provision in more deprived areas.19  
What is vital, however, is the need to prescribe carefully, particularly avoiding the 
use of TCAs, which can be lethal in overdose.16 While this is a clear ‘Do Not Do’ 
NICE recommendation15, it is of concern that it is not being effectively implemented 
in practice. A simple alert on the primary care computer system would go a long way 
to reminding prescribers about the dangers of TCAs, and the NICE ‘Do Not Do’ 
recommendation, in people who have one or more self-harm episodes recorded in 
their notes. 
  
We hope that our Editorial will highlight this patient safety concern and stark example 
of the Inverse Care Law, and draw attention to current recommendations for the 
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We would like to recommend that the following list is published alongside the editorial. 
 
 
Self-help and support 
Samaritans: Telephone and email support for anyone who is worried, upset, or suicidal; 
08457 90 90 90; ROI 116 123; email: jo@samaritans.org. 
PAPYRUS HOPELine UK: a professionally staffed helpline providing support, practical 
advice and information to young people worried about themselves, and to anyone concerned 
that a young person may harm themselves. Tel: 0800 068 41 41. 
Get Connected: offers help by telephone and email for people under 25 who self-harm. Tel: 
0808 808 4994. 
Selfharm.co.uk: a project dedicated to supporting young people who are affected by self-
harm. Email: info@selfharm.co.uk. 
Self Injury Support: provides a young women's text and email service, any age helpline for 
women who self-harm, UK-wide listings for self-harm support and self-help tools. 
Email: info@selfinjurysupport.org.uk. 
 
 
 
 
 
 
 
